Correlation Between Sabre Corpo and Pharmala Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sabre Corpo and Pharmala Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sabre Corpo and Pharmala Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sabre Corpo and Pharmala Biotech Holdings, you can compare the effects of market volatilities on Sabre Corpo and Pharmala Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sabre Corpo with a short position of Pharmala Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sabre Corpo and Pharmala Biotech.

Diversification Opportunities for Sabre Corpo and Pharmala Biotech

0.08
  Correlation Coefficient

Significant diversification

The 3 months correlation between Sabre and Pharmala is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Sabre Corpo and Pharmala Biotech Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharmala Biotech Holdings and Sabre Corpo is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sabre Corpo are associated (or correlated) with Pharmala Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharmala Biotech Holdings has no effect on the direction of Sabre Corpo i.e., Sabre Corpo and Pharmala Biotech go up and down completely randomly.

Pair Corralation between Sabre Corpo and Pharmala Biotech

If you would invest  371.00  in Sabre Corpo on September 15, 2024 and sell it today you would earn a total of  19.00  from holding Sabre Corpo or generate 5.12% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy4.76%
ValuesDaily Returns

Sabre Corpo  vs.  Pharmala Biotech Holdings

 Performance 
       Timeline  
Sabre Corpo 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Sabre Corpo are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak fundamental drivers, Sabre Corpo reported solid returns over the last few months and may actually be approaching a breakup point.
Pharmala Biotech Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pharmala Biotech Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, Pharmala Biotech is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders.

Sabre Corpo and Pharmala Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sabre Corpo and Pharmala Biotech

The main advantage of trading using opposite Sabre Corpo and Pharmala Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sabre Corpo position performs unexpectedly, Pharmala Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharmala Biotech will offset losses from the drop in Pharmala Biotech's long position.
The idea behind Sabre Corpo and Pharmala Biotech Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites